Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
Explore this paper's citation graph
Summary
Findings suggest that there is marked platelet activation after coronary thrombolysis with streptokinase, and the increase in plateletactivation and thromboxane A2 biosynthesis may limit the therapeutic effect of intravenous strePTokinase in acute myocardial infarction.
- Type
- dissertation
- Published
- 1988-01-01
- Cited by
- 497
- References
- 46
- OpenAlex
- https://openalex.org/W3275505
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8715974
Keywords
Humanities, Mathematics, Philosophy
References
- Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.
- Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction.
- Pulmonary dysfunction associated with streptokinase therapy.
- Platelet Aggregation After Thrombolytic Therapy
- [Rapid physiological coagulation method in determination of fibrinogen].
- A radioimmunoassay for thromboxane B2.
- Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
- Non-Parametric Statistics for the Behavioral Sciences.
- Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
- In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
- Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction.
- Plasminogen: Purification from Human Plasma by Affinity Chromatography
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
- Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985
- Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.
- Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
- Estimated rate of prostacyclin secretion into the circulation of normal man.
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis.
- 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
- Augmentation of Streptokinase‐Induced Thrombolysis by Heparin and Prostacyclin
Cited by
- Enhanced platelet function in acute myocardial infarction is attenuated by streptokinase treatment
- Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.
- Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
- After coronary thrombolysis and reperfusion, what next?
- The effect of recombinant hirudin on arterial thrombosis.
- Heparin and Streptokinase
- Antithrombotic agents in coronary artery disease.
- Aspirin as an antithrombotic agent.
- Infarct Size Is Reduced and the Frequency of Non-Q-Wave Myocardial Infarctions Is Increased in Patients Using Aspirin at the Onset of Symptoms
- Combination of a Direct Thrombin Inhibitor and a Platelet Glycoprotein IIb/IIIa Blocking Peptide Facilitates and Maintains Reperfusion of Platelet-Rich Thrombus with Alteplase
- Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi.
- Is Heparin of Value in the Management of Acute Myocardial Infarction?
- Eicosanoid Production following One Bout of Exercise in Middle-Aged African American Pre- and Stage 1 Hypertensives
- A novel approach to arterial thrombolysis.
- Management of Acute Ischemic Coronary Syndromes: The Present and Future
- Immunological Detection of Activated Platelets in Clinical Disorders
- Heparin After Acute Myocardial Infarction
- Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1.
- Therapie mit Thrombozytenfunktionshemmern bei operativen Eingriffen
- The molecular, biochemical and human pharmacology of thromboxane A2 in renal disease.
Related papers
No related papers recorded.